Curcumin (Curcuminoid · Anti-inflammatory · Joint Health · Neuroprotective)
| Compound | Curcumin |
| Chemical class | Polyphenol — Curcuminoid (Diarylheptanoid) |
| CAS | 458-37-7 |
| Primary source | Curcuma longa (turmeric rhizome) |
| Key applications | Anti-inflammatory, antioxidant, neuroprotective, joint health |
| Claim strength | Moderate |
| Typical form | Curcumin 95% extract; Tetrahydrocurcumin 95%; bioavailability-enhanced curcumin (phytosome, nanoparticle, BCM-95) |
| Buy from Herbuno |
Curcumin 95% Extract Powder - Curcuma longa → Tetrahydrocurcumin 95% Powder (Turmeric) | High-Purity Isolate | Curcuma longa → |
Name origin: From Curcuma — the genus of turmeric, derived from Arabic kurkum (saffron, due to the yellow colour). Curcumin is the primary curcuminoid in turmeric (constituting ~70–75% of total curcuminoids), alongside demethoxycurcumin (~20%) and bisdemethoxycurcumin (~5%). It is the characteristic yellow pigment of turmeric and the primary pharmacological active. Traditional use: Turmeric (Haldi in Hindi, Jiang Huang in TCM) has been used as a spice, food colourant, and medicine for over 4,000 years across South Asian, Southeast Asian, and Chinese traditions. Ayurvedic applications include joint pain, digestive complaints, wound healing, skin conditions, and as a general anti-inflammatory and hepatoprotective herb. Research trajectory: Curcumin is one of the most extensively studied phytochemicals globally — over 10,000 scientific publications. Despite massive research investment, clinical translation has been partially limited by poor oral bioavailability (~1% absolute), which is now addressed through multiple enhanced delivery technologies that have produced more consistent human clinical results. Commercial source: Curcumin is commercially available as a high-purity curcuminoid extract (95% HPLC) from Curcuma longa rhizome, alongside Tetrahydrocurcumin 95% (the colourless reduced form) for applications requiring colour-neutral or enhanced-stability curcuminoid delivery. See sourcing options below.
Evidence for Curcumin Applications
Anti-inflammatory (NF-κB, COX, cytokine inhibition): Curcumin is one of the most comprehensively characterised natural NF-κB inhibitors. It inhibits COX-2, TNF-α, IL-1β, IL-6, and suppresses Nrf2-mediated antioxidant induction. Multiple human RCTs with bioavailability-enhanced curcumin show significant improvements in inflammatory markers (CRP, IL-6, TNF-α) in arthritis, metabolic syndrome, and inflammatory bowel disease populations. Claim strength: Moderate.
Joint health and osteoarthritis: Multiple human RCTs demonstrate curcumin (bioavailability-enhanced formulations) equivalent or superior to ibuprofen (400 mg/day) for osteoarthritis pain and function scores at doses of 500–1000 mg/day curcuminoids. This is one of the best-evidenced supplement applications for curcumin. Claim strength: High (multiple RCTs, including head-to-head vs NSAID).
Cognitive and neuroprotective: Curcumin reduces amyloid-beta aggregation, tau hyperphosphorylation, and neuroinflammation in Alzheimer’s disease models. Human RCTs with bioavailability-enhanced curcumin (Theracurmin, BCM-95) show improvements in memory performance and BDNF levels in cognitively normal and mildly impaired older adults. Claim strength: Moderate.
Curcumin 95% Extract Powder - Curcuma longa →
Tetrahydrocurcumin 95% Powder (Turmeric) | High-Purity Isolate | Curcuma longa →
Browse Standardised Extract Powders →
Dosage & Formulator Specification
Standard curcumin 95% powder: 500–2000 mg/day curcuminoids for anti-inflammatory applications. Due to poor bioavailability of standard curcumin (~1% absolute), bioavailability-enhanced forms are strongly preferred: curcumin-phytosome (Meriva) — 29-fold improved AUC; Theracurmin (nanoparticle, colloidal) — 27-fold improved; BCM-95 (turmeric oil blend) — 6-fold improved; Longvida (SLCP lipid matrix) — 65-fold improved free curcumin. Piperine co-administration (20 mg per 500 mg curcumin) increases AUC approximately 20-fold by inhibiting CYP1A2 and P-glycoprotein.
Herbuno’s Curcumin 95% is the standard pharmaceutical-grade curcuminoid extract appropriate for formulations using piperine-enhanced delivery or as the base for phytosome preparation. Herbuno’s Tetrahydrocurcumin 95% is the reduced (hydrogenated) form — colourless, with superior stability and potentially better CNS bioavailability for cognitive applications.
Standard curcumin 95% is orange-yellow and imparts intense colour to any formulation — relevant for capsule/tablet fill colour management. Tetrahydrocurcumin is white/off-white and colour-neutral — preferred for light-coloured finished products. Both are heat-stable and compatible with standard manufacturing processes.
Frequently Asked Questions — Curcumin
Why is standard curcumin 95% considered poorly bioavailable?
Curcumin has three bioavailability barriers: (1) poor aqueous solubility (~11 ng/mL at neutral pH); (2) rapid phase II metabolism (sulphation and glucuronidation in the gut and liver, reducing intact curcumin plasma levels); (3) rapid intestinal efflux via P-glycoprotein. Standard oral dosing results in measurable blood levels only at gram-level doses. All major bioavailability-enhanced formats address one or more of these barriers: phytosomes improve solubility via phospholipid complexation; piperine inhibits phase II enzymes and P-gp; nanoparticles improve solubility and mucosal contact.
What is tetrahydrocurcumin and when should it be used instead of standard curcumin?
Tetrahydrocurcumin (THC) is curcumin with the three double bonds in the heptanoid chain reduced. This makes it: (1) colourless (preferred for clear or light-coloured formulations); (2) more chemically stable (the conjugated diene system responsible for curcumin’s colour is also responsible for much of its instability); (3) potentially better absorbed intact (reduced conjugation changes metabolism profile). THC retains strong antioxidant and anti-inflammatory activity with potentially better bioavailability profile for CNS and skin applications. Herbuno’s Tetrahydrocurcumin 95% is directly applicable.
Is curcumin from Lakadong turmeric (Herbuno) superior to standard curcumin?
Lakadong turmeric (Curcuma longa from Meghalaya, India) has exceptionally high curcuminoid content — typically 6–9% curcuminoids versus 2–5% in standard commercial turmeric. This makes Lakadong powder a natural high-curcuminoid turmeric for functional food applications where whole-turmeric inclusion is desired. For supplement formulations requiring precisely standardised curcumin content, Herbuno’s 95% curcuminoid extract provides more controlled dosing than even high-curcuminoid turmeric powder.
Can curcumin interact with chemotherapy drugs?
Curcumin has documented CYP3A4, CYP1A2, and P-glycoprotein inhibitory activity at higher concentrations, which could theoretically affect metabolism of chemotherapy agents. In vitro data also suggest curcumin may potentiate or antagonise certain cytotoxic drugs depending on the agent and timing. Oncology use of curcumin supplements warrants medical supervision and should include advisory language recommending oncologist consultation.
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery